TH
Tapan Haresh Sanghvi
About Tapan Haresh Sanghvi
Data last updated:
Tapan Haresh Sanghvi is a Director at U S Pharma (India) Private Limited (since 2014), Director at Oceanic Laboratories Private Limited (since 2021) and Non- Individual Subscriber at U S Medi Science (India) Private Limited (since 2026), and holds 1 more current directorship. The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹95.66 Cr; the largest is U S Pharma (India) Private Limited at ₹89.26 Cr (FY 2025). Earlier, Tapan Haresh Sanghvi was a Managing Director at Hexagen Pharma Ind Private Limited (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 U S Pharma (India) Private Limited U24230MH2003PTC140514 | Director | 12 Dec 2014 | 2003 | ₹89.26 Cr (FY 2025) | Active |
 Oceanic Laboratories Private Limited U24100MH1991PTC061013 | Director | 09 Mar 2021 | 1991 | ₹6.40 Cr (FY 2024) | Active |
| U S Medi Science (India) Private Limited U32509MR2026PTC480015 | Non- Individual Subscriber | 22 Aug 2026 | 2026 | Active | |
| Euro Medicare Laboratories Llp AAM-7820 | Designated Partner | 07 Jun 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Hexagen Pharma Ind Private Limited U74120MH2013PTC244991 | Managing Director | 29 Jun 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Tapan Haresh Sanghvi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mansi Tapan Sanghvi | 07736756 | U S Pharma (India) Private Limited , Oceanic Laboratories Private Limited and 2 more | Director |
| Chetan Khantilal Sanghavi | 09074834 | Oceanic Laboratories Private Limited | Director |
| Hareshkumar Pravinchandra Sanghvi | 09096675 | Oceanic Laboratories Private Limited , U S Medi Science (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tapan Haresh Sanghvi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tapan Haresh Sanghvi
Tapan Haresh Sanghvi currently holds 4 directorships: U S Pharma (India) Private Limited (Director, since 12 Dec 2014, revenue ₹89.26 Cr (FY 2025)); Oceanic Laboratories Private Limited (Director, since 09 Mar 2021, revenue ₹6.40 Cr (FY 2024)); U S Medi Science (India) Private Limited (Non- Individual Subscriber, since 22 Aug 2026); Euro Medicare Laboratories Llp (Designated Partner, since 07 Jun 2018).
Tapan Haresh Sanghvi was first appointed on 29 Jun 2013 as Managing Director at Hexagen Pharma Ind Private Limited. The most recent appointment on record is 22 Aug 2026 at U S Medi Science (India) Private Limited.
The 2 current companies of Tapan Haresh Sanghvi that report revenue have a combined latest revenue of ₹95.66 Cr: U S Pharma (India) Private Limited ₹89.26 Cr (FY 2025); Oceanic Laboratories Private Limited ₹6.40 Cr (FY 2024).
Tapan Haresh Sanghvi held 1 earlier board appointment: Hexagen Pharma Ind Private Limited (Managing Director, from 29 Jun 2013).
The current boards of Tapan Haresh Sanghvi's companies include Mansi Tapan Sanghvi (U S Pharma (India) Private Limited), Chetan Khantilal Sanghavi (Oceanic Laboratories Private Limited), Hareshkumar Pravinchandra Sanghvi (Oceanic Laboratories Private Limited).